Lifearc
Records under this name other than the patents Lifearc holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 5 of 5 · Back to Lifearc
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,718,686 | Anti-Transglutaminase 2 Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 11,136,338 | Fused Thiazolopyrimidine Derivatives As MNKS Inhibitors Lapsed on the fee record Ended Oct 5, 2025 · Medium confidence | Lapsed on the fee record | Ended Oct 5, 2025 | Medium confidence |
| US 10,961,233 | Oxazole derivatives for use in the treatment of cancer Lapsed on the fee record Ended Mar 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2025 | From the USPTO record |
| US 10,961,234 | Oxazole derivatives for use in the treatment of cancer Lapsed on the fee record Ended Mar 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2025 | From the USPTO record |
| US 9,193,781 | Hepatitis C virus antibodies Formerly held Lapsed on the fee record Ended Nov 24, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 24, 2023 | From the USPTO record |